2017
DOI: 10.1101/145706
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Multiple antibodies identify glypican-1 associated with exosomes from pancreatic cancer cells and serum from patients with pancreatic cancer

Abstract: Exosomes are man-sized vesicles shed by all cells, including cancer cells. Exosomes can serve as novel liquid biopsies for diagnosis of cancer with potential prognostic value. The exact mechanism/s associated with sorting or enrichment of cellular components into exosomes are still largely unknown. We reported Glypican-1 (GPC1) on the surface of cancer exosomes and provided evidence for the enrichment of GPC1 in exosomes from patients with pancreatic cancer1. Several different laboratories have validated this … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…24 There is a growing body of evidence demonstrating the potential of GPC-1 as a biomarker for pancreatic cancer, with several reports demonstrating correlation between serum levels of presumably tumor derived GPC-1 + exosomes with PDAC. 98,99 However, there is no consensus, as some reports have shown no correlation between the two -an area yet to be clarified by future work in the field. 91,98,100,101 Functional experiments explain a biological role for increased expression of GPC-1 in PDAC.…”
Section: Pancreatic Cancermentioning
confidence: 99%
“…24 There is a growing body of evidence demonstrating the potential of GPC-1 as a biomarker for pancreatic cancer, with several reports demonstrating correlation between serum levels of presumably tumor derived GPC-1 + exosomes with PDAC. 98,99 However, there is no consensus, as some reports have shown no correlation between the two -an area yet to be clarified by future work in the field. 91,98,100,101 Functional experiments explain a biological role for increased expression of GPC-1 in PDAC.…”
Section: Pancreatic Cancermentioning
confidence: 99%